Content Loading...
Content Loading...

Drug Discovery Safety & Liability Screening Panel
In the high-stakes business of drug development, early safety assessment across a range of targets is critical. When you know everything you can about your drug candidates—including potentially devastating off-target liabilities—you’re able to avoid costly errors and quicken the pace toward developing compounds that offer the greatest promise of success. Know More About Your Drug Candidates
The new Millipore Drug Discovery Safety & Liability Screening Panel addresses this critical need by providing industry-leading, functional profiling against 125 GPCR, kinase, ion channel and phosphatase targets. These targets were specifically chosen for their relevance to critical diseases and processes, including neurotoxicity, cardiac function, immunoprotection, diabetes, inflammation and gastrointestinal liability. Millipore’s Drug Discovery Safety & Liability Screening Panel offers:
- 125 critical safety targets across four target classes
- Recognized quality and service from four of our premier functional profiling services—KinaseProfiler, PhosphataseProfiler, GPCRProfiler and CardiacProfiler—in one convenient service panel
- Single compound shipping point to your choice of the US or UK, reducing your shipping and administrative costs
- Convenient monthly schedule with three-week turnaround time from compound submission deadline
- Secure access to your constituent reports as soon as they are completed via the Millipore online Drug Discovery Portal
- Valuable insight into your compound’s potential off-target liabilities at an extraordinary value
For more information, contact Millipore's Drug Discovery Services team at
drugdiscovery@millipore.com.
View Sample Data
Targets Available in the Drug Discovery Safety & Liabilty Screening Panel
| Protein Kinase - radiometric enzyme assay |
| AGC | PKA | human |
 | PKBβ | human |
 | PKCm | human |
 | PKCz | human |
 | PKCα | human |
 | PKCβI | human |
 | PKCβII | human |
 | PKCγ | human |
 | PKCδ | human |
 | PKCε | human |
 | PKCη | human |
 | PKCθ | human |
 | PKCι | human |
 | PKG1ß | human |
 | PKG1α | human |
 | ROCK-II | human |
| CAMK | AMPK | rat |
 | CaMKII β | human |
 | CaMKII γ | human |
 | CaMKII δ | human |
 | LKB1 | human |
| CMGC | CDK1/cyclinB | human |
 | CDK2/cyclinA | human |
 | CDK2/cyclinE | human |
 | CDK3/cyclinE | human |
 | CDK5/p25 | human |
 | CDK5/p35 | human |
 | CDK7/cyclinH/MAT1 | human |
 | CDK9/cyclinT1 | human |
 | GSK3b | human |
 | MAPK1 | human |
 | MAPK2 | human |
 | p70 S6 Kinase | human |
 | SAPK2a | human |
| Misc | PhKγ2 | human |
| TK | Abl | human |
 | Flt3 | human |
 | IR | human |
| | Lyn | human |
| Protein Phosphatase - fluorescent enzyme assay |
| Tyrosine phosphatase | PTP1B | human |
| | TCPTP | human |
| Ion Channel - cellular electrophysiology assay |
| Voltage-gated sodium channel | Nav1.5 | human |
| Inactivating potassium channel | hKv4.3/hKChIP2 | human |
| Voltage-gated calcium channel | L-type Calcium (Cav1.2) | human |
| Ultra-rapid potassium channel | hKv1.5 | human |
| Slow potassium channel | hKCNQ1/hminK | human |
| Rapid potassium channel | hERG | human |
Hyperpolarization gated channel
| hHCN4
hKir2.1 | human
human |
|  |
| GPCR - cellular calcium flux assay |
| Acetylcholine (muscarinic) | M1 | human |
 | M2 | human |
 | M3 | human |
| Adenosine | A1 | human |
 | A3 | human |
| Adrenergic | alpha1A | human |
 | alpha1D | human |
 | alpha2A | human |
 | beta 1 | human |
 | beta 2 | human |
| Anaphylotoxin | C5aR | human |
| Angiotensin | AT1 | human |
| Bombesin | BB2 | human |
| Bradykinin | B2 | human |
| Calcitonin | CGPR1 | human |
| Cannabinoid | CB1 | human |
 | CB2 | human |
| Chemokine | CCR1 | human |
 | CCR2B | human |
 | CX3CR1 | human |
 | CXCR1 | human |
| Cholecystokinin | CCK2 | human |
| CRF Receptor | CRF1 | human |
| Dopamine | D1 | human |
 | D2L | human |
 | D5 | human |
| Endothelin | ETA | human |
 | ETB | human |
| Galanin | GAL1 | human |
| Glycoprotein hormone | TSH | human |
| GnRH | GnRH / LHRH | human |
| Histamine | H1 | human |
 | H2 | human |
 | H3 | human |
| Leukotriene | BLT1 | human |
 | CysLT1 | human |
| Lysophospholipid | LPA1 | human |
 | LPA3 | human |
 | S1P3 | human |
| Melanocortin | MC5 | human |
| Motilin | Motilin receptor, MTLR | human |
| Neuromedin U | NMU1 | human |
| Neuropeptide Y | Y2 | human |
| Neurotensin | NTR1 | human |
| N-formylpeptide | FPR1 | human |
| Nicotinic Acid | GPR109A | human |
| Opioid | Delta | human |
 | Kappa | human |
 | Mu | human |
| Orexin | OX1 | human |
| Oxytocin | OT | human |
| P2Y / Purinergic (metabotropic) | P2Y1 | human |
| Platelet Activating Factor | PAF | human |
| Prokineticin | PK1 | human |
| Prolactin-releasing peptide | PRP | human |
| Prostanoid | DP | human |
 | EP2 | human |
 | EP3 | human |
 | FP | human |
 | IP1 | human |
 | TP | human |
| Protease-activated | PAR4 | human |
| PTH receptor | PTH1 | human |
| Serotonin | 5-HT1A | human |
 | 5-HT2A | human |
 | 5-HT2B | human |
 | 5-HT2C | human |
| Somatostatin | SST4 | human |
| Tackykinin /neurokinin | NK1 | human |
 | NK3 | human |
| Urotensin II | UT / GPR14 | human |
| Vasopressin | V1A | human |
 | V2 | human |
| VIP/PACAP | PAC1 long isoform | human |
 | VPAC1 | human |
 | VPAC2 | human |
|
 |  |  |
<< back to top